<qa>  What is the response rate for patients with low and intermediate grade non-HodgkinI. To evaluate response rate when bryostatin 1 is given in combination with vincristine in patients with low and intermediate grade non-Hodgkins lymphoma who have progressed or relapsed following an autologous bone marrow or stem cell transplant. 